May ELISA tests replace IIF in the diagnostic work-up of patients with suspected ANCA-associated vasculitis? The answer is clearly yes according to recently published results of the European Vasculitis Study Group.1
It’s Great When There’s Something to Celebrate!
Last week we had such an occasion at ORGENTEC Diagnostika. The February issue of the Annals of the Rheumatic Diseases, the EULAR Journal, included the results of a clinical evaluation study of our Anti-PR3 hs ELISA. The results are very gratifying for us and reflected well on our product.
The subject of the article? – The effectiveness of our test for the diagnosis of ANCA-associated vasculitis, abbreviated as AAV. This term encompasses autoimmune diseases characterized by the presence of antineutrophil cytoplasmic antibodies, known as ANCA. These diseases include Wegener’s granulomatosis (WG), microscopic polyangiitis (MPA), and Churg-Strauss syndrome (CSS). (more…)